Accéder au contenu
Merck

Examination of structurally selective derivatization of vitamin D(3) analogues by electrospray mass spectrometry.

Journal of mass spectrometry : JMS (2001-02-17)
A S Weiskopf, P Vouros, J Cunniff, E Binderup, F Björkling, L Binderup, M C White, G H Posner
RÉSUMÉ

The structural specificity of vitamin D derivatization by PTAD (4-phenyl-1,2,4-triazoline-3,5-dione) was probed using synthetic analogues and ion trap mass spectrometry. EB 1089, a vitamin D(3) analogue which contains a second site for Diels--Alder cycloaddition on its side-chain, allowed the examination of derivatization modes and comparisons of ion fragment structures. The origins of a PTAD-vitamin D(3) ion fragment, commonly used in metabolite characterization and quantitation of vitamin D(3) analogues (m/z 314), were established; ion trap mass spectrometry revealed that the PTAD comprises a portion of this diagnostic fragment, and is not lost by a retro-Diels--Alder step. Furthermore, the unique structure of the EB 1089 side-chain also permits facile determination of its side-chain metabolism. Use of PTAD derivatization and detection of metabolite-specific ion fragments identify hydroxylation at the end of the EB 1089 sidechain. It is believed that the results from these studies provide a clearer understanding of the mass spectrometry of triazolinedione derivatives, not only in the specific case of EB 1089, but also in their application to other vitamin D compounds.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
4-Phenyl-1,2,4-triazoline-3,5-dione, 97%